» Articles » PMID: 10713942

Dynamic Susceptibility Contrast MR Imaging: Correlation of Signal Intensity Changes with Cerebral Blood Volume Measurements

Overview
Date 2000 Mar 14
PMID 10713942
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral blood volume (CBV) maps derived from dynamic susceptibility contrast (DSC) magnetic resonance (MR) imaging provide valuable information regarding intracranial micro-hemodynamics and have been helpful in characterizing primary brain tumors and guiding stereotactic biopsy. Another parameter, the maximum signal drop (MSD) during the first pass of intravascular contrast bolus due to T2* effect, can also be measured directly without extensive post-processing and data manipulation. The purpose of our study is to determine whether MSD maps provide information similar to CBV maps in patients presenting with intracranial mass lesions. Twenty-nine patients with various intracranial mass lesions were studied with DSC MR imaging prior to stereotactic biopsy or volumetric resection. Maps of both CBV and MSD are calculated on a pixel-by-pixel basis and displayed as color overlays over the raw images. Relative CBV (rCBV) and MSD (rMSD) values were measured in regions of interest (ROIs) within areas of abnormality and compared. In addition, computer-generated noise was added to the data to estimate the sensitivity of each measurement to noise. The rMSD values were strongly correlated with rCBV values (r = 0.87, P = 0.0001). CBV values were much more sensitive to added noise than MSD values (P < 0.01). MSD maps derived from DSC MR imaging provide information similar to CBV maps in patients with intracranial mass lesions. MSD maps are a simple and reliable indicator of vascularity that can easily be incorporated into routine MR imaging.

Citing Articles

Advanced MRI Protocols to Discriminate Glioma From Treatment Effects: State of the Art and Future Directions.

Malik D, Rath T, Urcuyo Acevedo J, Canoll P, Swanson K, Boxerman J Front Radiol. 2023; 2:809373.

PMID: 37492687 PMC: 10365126. DOI: 10.3389/fradi.2022.809373.


Correlation between dynamic susceptibility contrast perfusion MRI and genomic alterations in glioblastoma.

Ozturk K, Soylu E, Cayci Z Neuroradiology. 2021; 63(11):1801-1810.

PMID: 33738509 DOI: 10.1007/s00234-021-02674-2.


Brain MR findings in patients treated with particle therapy for skull base tumors.

Viselner G, Farina L, Lucev F, Turpini E, Lungarotti L, Bacila A Insights Imaging. 2019; 10(1):94.

PMID: 31549243 PMC: 6757093. DOI: 10.1186/s13244-019-0784-9.


Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors.

Schmainda K, Prah M, Hu L, Quarles C, Semmineh N, Rand S AJNR Am J Neuroradiol. 2019; 40(4):626-633.

PMID: 30923088 PMC: 6461489. DOI: 10.3174/ajnr.A6015.


Correlation of Tumor Perfusion Between Carbon-13 Imaging with Hyperpolarized Pyruvate and Dynamic Susceptibility Contrast MRI in Pre-Clinical Model of Glioblastoma.

Park I, Lupo J, Nelson S Mol Imaging Biol. 2018; 21(4):626-632.

PMID: 30225760 PMC: 8172073. DOI: 10.1007/s11307-018-1275-y.